Endoscopic mucosal resection.
ASGE Technology Committee, Joo Ha Hwang, Vani Konda...
https://pubmed.ncbi.nlm.nih.gov/26077453Actively Recruiting
Led by Assaf-Harofeh Medical Center · Updated on 2026-01-13
200
Participants Needed
1
Research Sites
4 weeks
Total Duration
Researchers are evaluating the use of tranexamic acid (TXA) to prevent bleeding during and after endoscopic mucosal resection (EMR) of large colon polyps. EMR is a technique to remove superficial growths in the colon but can cause significant bleeding during and after the procedure. This study aims to compare the effects of local TXA injection versus standard treatment including adrenaline, focusing on reducing bleeding complications. Participants will be randomly assigned to receive either a submucosal injection of a standard solution containing TXA or a standard solution that includes adrenaline during the EMR procedure. The study is single-blinded and includes two groups: the TXA group and the standard therapy group. The trial evaluates bleeding rates during the procedure and within two weeks afterward to assess safety and effectiveness. During the study, participants will undergo the EMR procedure with assigned injections and be monitored for bleeding events both during and up to two weeks after the procedure. Researchers will collect data on intraprocedural and postprocedural bleeding, treatment side effects, and other relevant outcomes. The study involves follow-up visits to assess bleeding and recovery, and participation may last for a few weeks following the procedure.
CONDITIONS
Tranexamic Acid During Colonic Endoscopic Resection Procedures
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Day of the procedure
Participants undergo the endoscopic resection procedure with submucosal injection of either tranexamic acid or standard solution including adrenaline as part of the study intervention.
1 procedure visit (in-person)
Duration - Up to 2 weeks after the procedure
Participants are monitored for postprocedural bleeding and other outcomes following the endoscopic resection procedure.
Approximately 1 to 2 follow-up visits (in-person)
Total: 1 location
1
Shamir Medical Center
Be’er Ya‘aqov, Israel, 70300
Actively Recruiting
A
Anton Bermont, MD
S
Sergei Vosko, MD
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
ASGE Technology Committee, Joo Ha Hwang, Vani Konda...
https://pubmed.ncbi.nlm.nih.gov/26077453Chan Hyuk Park, Sang Kil Lee
https://pubmed.ncbi.nlm.nih.gov/24143302Farzan Fahrtash-Bahin, Bronte A Holt, Vanoo Jayasekeran...
https://pubmed.ncbi.nlm.nih.gov/23570622Hyun Seok Lee, Seong Woo Jeon, Yong Hwan Kwon...
https://pubmed.ncbi.nlm.nih.gov/31175874Hammad Liaquat, Elizabeth Rohn, Douglas K Rex
https://pubmed.ncbi.nlm.nih.gov/23317580Rui Castro, Diogo Libânio, Inês Pita...
https://pubmed.ncbi.nlm.nih.gov/30809079Douglas K Rex, Rachel E Lahr, Merritt M Peterson...
https://pubmed.ncbi.nlm.nih.gov/34896443Johnny Cai, Jessica Ribkoff, Sven Olson...
https://pubmed.ncbi.nlm.nih.gov/31729076Geoff Watts
https://pubmed.ncbi.nlm.nih.gov/27308678